EBSAX | MBXIX | EBSAX / MBXIX | |
Total Expense Ratio | 2.00 | 2.03 | 99% |
Annual Report Gross Expense Ratio | 2.09 | 2.03 | 103% |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 2.386 | -1.984 | -120% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2B | 8.05B | 25% |
Annual Yield % from dividends | 1.20 | 1.92 | 63% |
Returns for 1 year | 7.79 | -0.35 | -2,244% |
Returns for 3 years | 2.14 | 6.92 | 31% |
Returns for 5 years | 41.36 | 52.96 | 78% |
Returns for 10 years | 20.67 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSACX | 18.97 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq I | |||
SBHIX | 22.84 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
GSMYX | 23.03 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth Instl | |||
JLCFX | 69.60 | N/A | N/A |
JHancock Fundamental Large Cap Core R4 | |||
WSCRX | 33.77 | N/A | N/A |
Allspring Small Company Growth R6 |